SavedAdd your journal

Journals / Gazi Medical Journal / 2009 / Cilt: 20 - Sayı: 2

Hepatit B asısına bağlı guillain barre sendromu olgusu ve literatürün gözden geçirilmesi

Guillain-barre syndrome associated with hepatitis B vaccine and a review of the literature

Ayşe SERDAROĞLU
Ercan DEMİR
Aysima AKTÜRK
Çiğdem KASAPKAYA
Ebru ARHAN
Kıvılcım GÜCÜYENER
Pages
87–89
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mechanisms of this very ra complication are proposed along with a literature review.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We present a new case of Guillain-Barre syndrome following hepatitis B vaccin and review other cases in the literature.
📊
Key Findings & Data:A 14-year-old male patient developed facc paralysis after immunization with recombinant hepatitis B vaccine 14 days befor Cerebrospinal fuid analysis revealed acellular fuid with a high protein level.
💡
Conclusion & Impact:Mechanisms of this very ra complication are proposed along with a literature review.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We present a new case of Guillain-Barre syndrome following hepatitis B vaccin and review other cases in the literature. A 14-year-old male patient developed facc paralysis after immunization with recombinant hepatitis B vaccine 14 days befor Cerebrospinal fuid analysis revealed acellular fuid with a high protein level. Th nerve conduction study was compatible with motor polyneuropathy. Other potenti causes of Guillain-Barre syndrome were ruled out. Mechanisms of this very ra complication are proposed along with a literature review.

Özet

Hepatit B asısına bağlı yeni bir Guillain Barre olgusu sunarak literatürü gözdengeçirdik. 14 yasında erkek hasta 14 gün önce yapılan Hepatit B asısını takiben faskparalizi gelisti. Beyin omurilik sıvısı incelemesinde hücre yoktu ve proteini yüksekti.Sinir ileti çalısması demyelinizan polinöropati ile uyumlu idi. Guillain Barre nindiğer muhtemel sebepleri gösterilemedi. Bu nadir komplikasyonun mekanizmalarıliteratür gözden geçirilerek tartısılmıstır.

🔖

Cite This Article

SERDAROĞLU, A., DEMİR, E., AKTÜRK, A., KASAPKAYA, Ç., ARHAN, E., GÜCÜYENER, K. (2022). Hepatit B asısına bağlı guillain barre sendromu olgusu ve literatürün gözden geçirilmesi. Gazi Medical Journal, Cilt: 20 - Sayı: 2, 87–89. https://ajindex.com/articles/520295

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666
  2. Hahn AF. Guillain-Barre syndrome. Lancet. 1998; 352: 635-41
  3. Yuki N. Infectious origins of, and molecular mimicry in, GuillainBarre and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37
  4. Inglis HR, Csurhes PA, McCombe PA. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with infammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry 2007; 78: 419-22
  5. Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA. Antibodies to peripheral nerve myelin proteins in chronic infammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005; 10: 174-80. 6-Tam CC, O’Brien SJ, Rodrigues LC. Infuenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England. Emerg Infect Dis 2006; 12: 1880-7
  6. Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside speci- fcity and clinical features of Guillain-Barre and Miller Fisher patients. Infect Immun 2002; 70: 1202-8. 8-Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity’vaccinosis’: a dangerous liaison? J Autoimmun 2000; 14: 1-10 9-Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 15: 1659-66
  7. Carmeli Y, De-Medina T. Serious hepatitis B vaccine adverse reactions, are they immune-mediated? Vaccine 1993; 11: 1358-9. 11-Shaw FE Jr, Graham DJ, Guess HA, Milstien JB, Johnson JM, Schatz GC, Hadler SC, Kuritsky JN, Hiner EE, Bregman DJ, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the frst three years. Am J Epidemiol 1988; 127: 337-52
  8. Senejoux A, Roulot D, Belin C, Tsakiris L, Rautureau J, Coste T. Acute myelitis after immunization against hepatitis B with recombinant vaccine. Gastroenterol Clin Biol 1996; 20: 401-2. 13-Tuohy PG. Guillain-Barre syndrome following immunisation with synthetic hepatitis B vaccine. NZ Med J 1989; 102: 114-115
  9. Kakar A, Sethi PK. Guillain Barre syndrome associated with hepatitis B vaccination. Indian J Pediatr 1997; 64: 710-2
  10. Creange A, Temam G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999; 30: 143-146. 16-Sinsawaiwong S, Thampani